Humanized mouse models of Epstein-Barr virus infection and associated diseases

Pathogens

Volumn 2, Issue 1, 2013, Pages 153-176

  Fujiwara, Shigeyoshi ^a   Matsuda, Go ^a   Imadome, Ken Ichi ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Chronic active EBV infection; EBV associated hemophagocytic lymphohistiocytosis; Epstein Barr virus; Humanized mouse; Immune responses; Latent infection; Lymphoproliferative disease; Rheumatoid arthritis; Xenograft model

Indexed keywords

B LYMPHOCYTE RECEPTOR; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN M ANTIBODY;

CARCINOGENESIS; CD4+ T LYMPHOCYTE; DENDRITIC CELL; DISEASE ASSOCIATION; DNA POLYMORPHISM; EPITHELIUM CELL; EPSTEIN BARR VIRUS INFECTION; EXPERIMENTAL MOUSE; GENE EXPRESSION; HEMOPHAGOCYTIC SYNDROME; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LYMPHOPROLIFERATIVE DISEASE; MEMORY CELL; NONHUMAN; PHENOTYPIC VARIATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHEUMATOID ARTHRITIS; VIRUS PATHOGENESIS;

EID: 84887917678     PISSN: None     EISSN: 20760817     Source Type: Journal    
DOI: 10.3390/pathogens2010153     Document Type: Review

References (117)

1. Tripp, R.A.; Hamilton-Easton, A.M.; Cardin, R.D.; Nguyen, P.; Behm, F.G.; Woodland, D.L.; Doherty, P.C.; Blackman, M.A. Pathogenesis of an infectious mononucleosis-like disease induced by a murine gamma-herpesvirus: Role for a viral superantigen? J. Exp. Med. 1997, 185, 1641-1650.
2. Flano, E.; Woodland, D.L.; Blackman, M.A. A mouse model for infectious mononucleosis. Immunol. Res. 2002, 25, 201-217.
3. Reddehase, M.J.; Simon, C.O.; Seckert, C.K.; Lemmermann, N.; Grzimek, N.K. Murine model of cytomegalovirus latency and reactivation. Curr. Top. Microbiol. Immunol. 2008, 325, 315-331.
4. Wang, H.; Beyer, I.; Persson, J.; Song, H.; Li, Z.; Richter, M.; Cao, H.; van Rensburg, R.; Yao, X.; Hudkins, K., et al. A new human dsg2-transgenic mouse model for studying the tropism and pathology of human adenoviruses. J. Virol. 2012, 86, 6286-6302.
5. Sellin, C.I.; Horvat, B. Current animal models: Transgenic animal models for the study of measles pathogenesis. Curr. Top. Microbiol. Immunol. 2009, 330, 111-127.
6. Baric, R.S.; Sims, A.C. Humanized mice develop coronavirus respiratory disease. Proc. Natl. Acad. Sci. USA 2005, 102, 8073-8074.
7. Lassnig, C.; Sanchez, C.M.; Egerbacher, M.; Walter, I.; Majer, S.; Kolbe, T.; Pallares, P.; Enjuanes, L.; Muller, M. Development of a transgenic mouse model susceptible to human coronavirus 229e. Proc. Natl. Acad. Sci. USA. 2005, 102, 8275-8280.
8. Dorner, M.; Horwitz, J.A.; Robbins, J.B.; Barry, W.T.; Feng, Q.; Mu, K.; Jones, C.T.; Schoggins, J.W.; Catanese, M.T.; Burton, D.R., et al. A genetically humanized mouse model for hepatitis c virus infection. Nature 2011, 474, 208-211.
9. Bosma, G.C.; Custer, R.P.; Bosma, M.J. A severe combined immunodeficiency mutation in the mouse. Nature 1983, 301, 527-530.
10. McCune, J.M.; Namikawa, R.; Kaneshima, H.; Shultz, L.D.; Lieberman, M.; Weissman, I.L. The scid-hu mouse: Murine model for the analysis of human hematolymphoid differentiation and function. Science 1988, 241, 1632-1639.
11. Gobbi, A.; Stoddart, C.A.; Malnati, M.S.; Locatelli, G.; Santoro, F.; Abbey, N.W.; Bare, C.; Linquist-Stepps, V.; Moreno, M.B.; Herndier, B.G., et al. Human herpesvirus 6 (hhv-6) causes severe thymocyte depletion in scid-hu thy/liv mice. J. Exp. Med. 1999, 189, 1953-1960.
12. Kern, E.R.; Rybak, R.J.; Hartline, C.B.; Bidanset, D.J. Predictive efficacy of scid-hu mouse models for treatment of human cytomegalovirus infections. Antivir. Chem. Chemother. 2001, 12, 149-156.
13. Dittmer, D.; Stoddart, C.; Renne, R.; Linquist-Stepps, V.; Moreno, M.E.; Bare, C.; McCune, J.M.; Ganem, D. Experimental transmission of kaposi's sarcoma-associated herpesvirus (kshv/hhv-8) to scid-hu thy/liv mice. J. Exp. Med. 1999, 190, 1857-1868.
14. Valsamakis, A.; Auwaerter, P.G.; Rima, B.K.; Kaneshima, H.; Griffin, D.E. Altered virulence of vaccine strains of measles virus after prolonged replication in human tissue. J. Virol. 1999, 73, 8791-8797.
15. Moffat, J.F.; Zerboni, L.; Sommer, M.H.; Heineman, T.C.; Cohen, J.I.; Kaneshima, H.; Arvin, A.M. The orf47 and orf66 putative protein kinases of varicella-zoster virus determine tropism for human t cells and skin in the scid-hu mouse. Proc. Natl. Acad. Sci. USA 1998, 95, 11969-11974.
16. McCune, J.; Kaneshima, H.; Krowka, J.; Namikawa, R.; Outzen, H.; Peault, B.; Rabin, L.; Shih, C.C.; Yee, E.; Lieberman, M., et al. The scid-hu mouse: A small animal model for hiv infection and pathogenesis. Annu. Rev. Immunol. 1991, 9, 399-429.
17. Aldrovandi, G.M.; Feuer, G.; Gao, L.; Jamieson, B.; Kristeva, M.; Chen, I.S.; Zack, J.A. The scid-hu mouse as a model for hiv-1 infection. Nature 1993, 363, 732-736.
18. Van Duyne, R.; Pedati, C.; Guendel, I.; Carpio, L.; Kehn-Hall, K.; Saifuddin, M.; Kashanchi, F. The utilization of humanized mouse models for the study of human retroviral infections. Retrovirology 2009, 6, 76.
19. Mosier, D.E.; Gulizia, R.J.; Baird, S.M.; Wilson, D.B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988, 335, 256-259.
20. Mosier, D.E.; Gulizia, R.J.; Baird, S.M.; Wilson, D.B.; Spector, D.H.; Spector, S.A. Human immunodeficiency virus infection of human-pbl-scid mice. Science 1991, 251, 791-794.
21. Cannon, M.J.; Pisa, P.; Fox, R.I.; Cooper, N.R. Epstein-barr virus induces aggressive lymphoproliferative disorders of human b cell origin in scid/hu chimeric mice. J. Clin. Invest. 1990, 85, 1333-1337.
22. Feuer, G.; Zack, J.A.; Harrington, W.J., Jr.; Valderama, R.; Rosenblatt, J.D.; Wachsman, W.; Baird, S.M.; Chen, I.S. Establishment of human t-cell leukemia virus type i t-cell lymphomas in severe combined immunodeficient mice. Blood 1993, 82, 722-731.
23. Mosier, D.E. Viral pathogenesis in hu-pbl-scid mice. Semin. Immunol. 1996, 8, 255-262.
24. Traggiai, E.; Chicha, L.; Mazzucchelli, L.; Bronz, L.; Piffaretti, J.C.; Lanzavecchia, A.; Manz, M.G. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004, 304, 104-107.
25. Ito, M.; Hiramatsu, H.; Kobayashi, K.; Suzue, K.; Kawahata, M.; Hioki, K.; Ueyama, Y.; Koyanagi, Y.; Sugamura, K.; Tsuji, K., et al. Nod/scid/gamma(c)(null) mouse: An excellent recipient mouse model for engraftment of human cells. Blood 2002, 100, 3175-3182.
26. Melkus, M.W.; Estes, J.D.; Padgett-Thomas, A.; Gatlin, J.; Denton, P.W.; Othieno, F.A.; Wege, A.K.; Haase, A.T.; Garcia, J.V. Humanized mice mount specific adaptive and innate immune responses to EBV and tsst-1. Nat. Med. 2006, 12, 1316-1322.
27. Shultz, L.D.; Lyons, B.L.; Burzenski, L.M.; Gott, B.; Chen, X.; Chaleff, S.; Kotb, M.; Gillies, S.D.; King, M.; Mangada, J., et al. Human lymphoid and myeloid cell development in nod/ltsz-scid il2r gamma null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 2005, 174, 6477-6489.
28. Islas-Ohlmayer, M.; Padgett-Thomas, A.; Domiati-Saad, R.; Melkus, M.W.; Cravens, P.D.; Martin Mdel, P.; Netto, G.; Garcia, J.V. Experimental infection of nod/scid mice reconstituted with human cd34+ cells with epstein-barr virus. J. Virol. 2004, 78, 13891-13900.
29. Cocco, M.; Bellan, C.; Tussiwand, R.; Corti, D.; Traggiai, E.; Lazzi, S.; Mannucci, S.; Bronz, L.; Palummo, N.; Ginanneschi, C., et al. Cd34+ cord blood cell-transplanted rag2-/- gamma(c)-/- mice as a model for epstein-barr virus infection. Am. J. Pathol. 2008, 173, 1369-1378.
30. Yajima, M.; Imadome, K.; Nakagawa, A.; Watanabe, S.; Terashima, K.; Nakamura, H.; Ito, M.; Shimizu, N.; Honda, M.; Yamamoto, N., et al. A new humanized mouse model of epstein-barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J. Infect. Dis. 2008, 198, 673-682.
31. Strowig, T.; Gurer, C.; Ploss, A.; Liu, Y.F.; Arrey, F.; Sashihara, J.; Koo, G.; Rice, C.M.; Young, J.W.; Chadburn, A., et al. Priming of protective t cell responses against virus-induced tumors in mice with human immune system components. J. Exp. Med. 2009, 206, 1423-1434.
32. Watanabe, S.; Terashima, K.; Ohta, S.; Horibata, S.; Yajima, M.; Shiozawa, Y.; Dewan, M.Z.; Yu, Z.; Ito, M.; Morio, T., et al. Hematopoietic stem cell-engrafted nod/scid/il2rgamma null mice develop human lymphoid systems and induce long-lasting hiv-1 infection with specific humoral immune responses. Blood 2007, 109, 212-218.
33. Baenziger, S.; Tussiwand, R.; Schlaepfer, E.; Mazzucchelli, L.; Heikenwalder, M.; Kurrer, M.O.; Behnke, S.; Frey, J.; Oxenius, A.; Joller, H., et al. Disseminated and sustained hiv infection in cd34+ cord blood cell-transplanted rag2-/-gamma c-/- mice. Proc. Natl. Acad. Sci. USA 2006, 103, 15951-15956.
34. Sun, Z.; Denton, P.W.; Estes, J.D.; Othieno, F.A.; Wei, B.L.; Wege, A.K.; Melkus, M.W.; Padgett-Thomas, A.; Zupancic, M.; Haase, A.T., et al. Intrarectal transmission, systemic infection, and cd4+ t cell depletion in humanized mice infected with hiv-1. J. Exp. Med. 2007, 204, 705-714.
35. Zhang, L.; Kovalev, G.I.; Su, L. Hiv-1 infection and pathogenesis in a novel humanized mouse model. Blood 2007, 109, 2978-2981.
36. Berges, B.K.; Wheat, W.H.; Palmer, B.E.; Connick, E.; Akkina, R. Hiv-1 infection and cd4 t cell depletion in the humanized rag2-/-gamma c-/- (rag-hu) mouse model. Retrovirology 2006, 3, 76.
37. Miyazato, P.; Yasunaga, J.; Taniguchi, Y.; Koyanagi, Y.; Mitsuya, H.; Matsuoka, M. De novo human t-cell leukemia virus type 1 infection of human lymphocytes in nod-scid, common gamma-chain knockout mice. J. Virol. 2006, 80, 10683-10691.
38. Takajo, I.; Umeki, K.; Morishita, K.; Yamamoto, I.; Kubuki, Y.; Hatakeyama, K.; Kataoka, H.; Okayama, A. Engraftment of peripheral blood mononuclear cells from human t-lymphotropic virus type 1 carriers in nod/scid/gammac(null) (nog) mice. Int. J. Cancer 2007, 121, 2205-2211.
39. Banerjee, P.; Tripp, A.; Lairmore, M.D.; Crawford, L.; Sieburg, M.; Ramos, J.C.; Harrington, W. Jr.; Beilke, M.A.; Feuer, G. Adult t-cell leukemia/lymphoma development in htlv-1-infected humanized scid mice. Blood 2010, 115, 2640-2648.
40. Bente, D.A.; Melkus, M.W.; Garcia, J.V.; Rico-Hesse, R. Dengue fever in humanized nod/scid mice. J. Virol. 2005, 79, 13797-13799.
41. Kuruvilla, J.G.; Troyer, R.M.; Devi, S.; Akkina, R. Dengue virus infection and immune response in humanized rag2(-/-)gamma(c)(-/-) (rag-hu) mice. Virology 2007, 369, 143-152.
42. Kwant-Mitchell, A.; Ashkar, A.A.; Rosenthal, K.L. Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model. J. Virol. 2009, 83, 10664-10676.
43. Parsons, C.H.; Adang, L.A.; Overdevest, J.; O'Connor, C.M.; Taylor, J.R., Jr.; Camerini, D.; Kedes, D.H. Kshv targets multiple leukocyte lineages during long-term productive infection in nod/scid mice. J. Clin. Invest. 2006, 116, 1963-1973.
44. Yu, C.I.; Gallegos, M.; Marches, F.; Zurawski, G.; Ramilo, O.; Garcia-Sastre, A.; Banchereau, J.; Palucka, A.K. Broad influenza-specific cd8+ t-cell responses in humanized mice vaccinated with influenza virus vaccines. Blood 2008, 112, 3671-3678.
45. Tu, W.; Zheng, J.; Liu, Y.; Sia, S.F.; Liu, M.; Qin, G.; Ng, I.H.; Xiang, Z.; Lam, K.T.; Peiris, J.S., et al. The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a gammadelta t cell population in humanized mice. J. Exp. Med. 2011, 208, 1511-1522.
46. Bissig, K.D.; Wieland, S.F.; Tran, P.; Isogawa, M.; Le, T.T.; Chisari, F.V.; Verma, I.M. Human liver chimeric mice provide a model for hepatitis b and c virus infection and treatment. J. Clin. Invest. 2010, 120, 924-930.
47. Dandri, M.; Burda, M.R.; Torok, E.; Pollok, J.M.; Iwanska, A.; Sommer, G.; Rogiers, X.; Rogler, C.E.; Gupta, S.; Will, H., et al. Repopulation of mouse liver with human hepatocytes and In vivo infection with hepatitis b virus. Hepatology 2001, 33, 981-988.
48. Mercer, D.F.; Schiller, D.E.; Elliott, J.F.; Douglas, D.N.; Hao, C.; Rinfret, A.; Addison, W.R.; Fischer, K.P.; Churchill, T.A.; Lakey, J.R., et al. Hepatitis c virus replication in mice with chimeric human livers. Nat. Med. 2001, 7, 927-933.
49. Washburn, M.L.; Bility, M.T.; Zhang, L.; Kovalev, G.I.; Buntzman, A.; Frelinger, J.A.; Barry, W.; Ploss, A.; Rice, C.M.; Su, L. A humanized mouse model to study hepatitis c virus infection, immune response, and liver disease. Gastroenterology 2011, 140, 1334-1344.
50. Villaudy, J.; Wencker, M.; Gadot, N.; Gillet, N.A.; Scoazec, J.Y.; Gazzolo, L.; Manz, M.G.; Bangham, C.R.; Dodon, M.D. Htlv-1 propels thymic human t cell development in human immune system rag2(-)/(-) gamma c(-)/(-) mice. PLoS Pathog 2011, 7, e1002231.
51. Kuwana, Y.; Takei, M.; Yajima, M.; Imadome, K.; Inomata, H.; Shiozaki, M.; Ikumi, N.; Nozaki, T.; Shiraiwa, H.; Kitamura, N., et al. Epstein-barr virus induces erosive arthritis in humanized mice. PLoS One 2011, 6, e26630.
52. Yajima, M.; Imadome, K.; Nakagawa, A.; Watanabe, S.; Terashima, K.; Nakamura, H.; Ito, M.; Shimizu, N.; Yamamoto, N.; Fujiwara, S. T cell-mediated control of epstein-barr virus infection in humanized mice. J. Infect. Dis. 2009, 200, 1611-1615.
53. Sato, K.; Misawa, N.; Nie, C.; Satou, Y.; Iwakiri, D.; Matsuoka, M.; Takahashi, R.; Kuzushima, K.; Ito, M.; Takada, K., et al. A novel animal model of epstein-barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice. Blood 2011, 117, 5663-5673.
54. Watanabe, S.; Ohta, S.; Yajima, M.; Terashima, K.; Ito, M.; Mugishima, H.; Fujiwara, S.; Shimizu, K.; Honda, M.; Shimizu, N., et al. Humanized nod/scid/il2r{gamma}null mice transplanted with hematopoietic stem cells under non-myeloablative condition show prolonged lifespans and allow detailed analysis of hiv-1 pathogenesis. J. Virol. 2007.
55. Kumar, P.; Ban, H.S.; Kim, S.S.; Wu, H.; Pearson, T.; Greiner, D.L.; Laouar, A.; Yao, J.; Haridas, V.; Habiro, K., et al. T cell-specific sirna delivery suppresses hiv-1 infection in humanized mice. Cell 2008, 134, 577-586.
56. Smith, M.S.; Goldman, D.C.; Bailey, A.S.; Pfaffle, D.L.; Kreklywich, C.N.; Spencer, D.B.; Othieno, F.A.; Streblow, D.N.; Garcia, J.V.; Fleming, W.H., et al. Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model. Cell Host Microbe 2010, 8, 284-291.
57. Mota, J.; Rico-Hesse, R. Dengue virus tropism in humanized mice recapitulates human dengue fever. PLoS One 2011, 6, e20762.
58. Boss, I.W.; Nadeau, P.E.; Abbott, J.R.; Yang, Y.; Mergia, A.; Renne, R. A kaposi's sarcoma-associated herpesvirus-encoded ortholog of microrna mir-155 induces human splenic b-cell expansion in nod/ltsz-scid il2rgammanull mice. J. Virol. 2011, 85, 9877-9886.
59. Marodon, G.; Desjardins, D.; Mercey, L.; Baillou, C.; Parent, P.; Manuel, M.; Caux, C.; Bellier, B.; Pasqual, N.; Klatzmann, D. High diversity of the immune repertoire in humanized nod.Scid.Gamma c-/- mice. Eur. J. Immunol. 2009, 39, 2136-2145.
60. Brainard, D.M.; Seung, E.; Frahm, N.; Cariappa, A.; Bailey, C.C.; Hart, W.K.; Shin, H.S.; Brooks, S.F.; Knight, H.L.; Eichbaum, Q., et al. Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized blt mice. J. Virol. 2009, 83, 7305-7321.
61. Jaiswal, S.; Pazoles, P.; Woda, M.; Shultz, L.D.; Greiner, D.L.; Brehm, M.A.; Mathew, A. Enhanced humoral and hla-a2-restricted dengue virus-specific t-cell responses in humanized blt nsg mice. Immunology 2012, 136, 334-343.
62. Ma, S.D.; Hegde, S.; Young, K.H.; Sullivan, R.; Rajesh, D.; Zhou, Y.; Jankowska-Gan, E.; Burlingham, W.J.; Sun, X.; Gulley, M.L., et al. A new model of epstein-barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas. J. Virol. 2011, 85, 165-177.
63. Ma, S.D.; Yu, X.; Mertz, J.E.; Gumperz, J.E.; Reinheim, E.; Zhou, Y.; Tang, W.; Burlingham, W.J.; Gulley, M.L.; Kenney, S.C. An epstein-barr virus (EBV) mutant with enhanced bzlf1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model. J. Virol. 2012, 86, 7976-7987.
64. Rickinson, A.B.; Kieff, E.D. Epstein-barr virus. In Fields Virology, 5th ed.; Knipe, D.M., Howley, P.M., Eds; Lippincott Williams and Wilkins: Philadelphia, PA, USA, 2007; Volume 2, pp. 2655-2700.
65. Hislop, A.D.; Taylor, G.S.; Sauce, D.; Rickinson, A.B. Cellular responses to viral infection in humans: Lessons from epstein-barr virus. Annu. Rev. Immunol. 2007, 25, 587-617.
66. Zhang, B.; Kracker, S.; Yasuda, T.; Casola, S.; Vanneman, M.; Homig-Holzel, C.; Wang, Z.; Derudder, E.; Li, S.; Chakraborty, T., et al. Immune surveillance and therapy of lymphomas driven by epstein-barr virus protein lmp1 in a mouse model. Cell 2012, 148, 739-751.
67. Kieff, E.D.; Rickinson, A.B. Epstein-barr virus and its replication. In Fields Virology; Knipe, D.M., Howley, P.M., Eds.; Lippincott Williams and Wilkins: Philadelphia, PA, USA, 2007; Volume 2, pp. 2603-2654.
68. Shope, T.; Dechairo, D.; Miller, G. Malignant lymphoma in cottontop marmosets after inoculation with epstein-barr virus. Proc. Natl. Acad. Sci. USA 1973, 70, 2487-2491.
69. Johannessen, I.; Crawford, D.H. In vivo models for epstein-barr virus (EBV)-associated b cell lymphoproliferative disease (blpd). Rev. Med. Virol. 1999, 9, 263-277.
70. Epstein, M.A.; zur Hausen, H.; Ball, G.; Rabin, H. Pilot experiments with eb virus in owl monkeys (aotus trivirgatus). Iii. Serological and biochemical findings in an animal with reticuloproliferative disease. Int. J. Cancer 1975, 15, 17-22.
71. Takashima, K.; Ohashi, M.; Kitamura, Y.; Ando, K.; Nagashima, K.; Sugihara, H.; Okuno, K.; Sairenji, T.; Hayashi, K. A new animal model for primary and persistent epstein-barr virus infection: Human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis. J. Med. Virol. 2008, 80, 455-466.
72. Epstein, M.A.; Morgan, A.J.; Finerty, S.; Randle, B.J.; Kirkwood, J.K. Protection of cottontop tamarins against epstein-barr virus-induced malignant lymphoma by a prototype subunit vaccine. Nature 1985, 318, 287-289.
73. Moghaddam, A.; Rosenzweig, M.; Lee-Parritz, D.; Annis, B.; Johnson, R.P.; Wang, F. An animal model for acute and persistent epstein-barr virus infection. Science 1997, 276, 2030-2033.
74. Wang, F. A new animal model for epstein-barr virus pathogenesis. Curr. Top. Microbiol. Immunol. 2001, 258, 201-219.
75. Rowe, M.; Young, L.S.; Crocker, J.; Stokes, H.; Henderson, S.; Rickinson, A.B. Epstein-barr virus (EBV)-associated lymphoproliferative disease in the scid mouse model: Implications for the pathogenesis of EBV-positive lymphomas in man. J. Exp. Med. 1991, 173, 147-158.
76. Mosier, D.E.; Gulizia, R.J.; Baird, S.M.; Spector, S.; Spector, D.; Kipps, T.J.; Fox, R.I.; Carson, D.A.; Cooper, N.; Richman, D.D., et al. Studies of hiv infection and the development of epstein-barr virus-related b cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency. Curr. Top Microbiol. Immunol. 1989, 152, 195-199.
77. Veronese, M.L.; Veronesi, A.; D'Andrea, E.; Del Mistro, A.; Indraccolo, S.; Mazza, M.R.; Mion, M.; Zamarchi, R.; Menin, C.; Panozzo, M., et al. Lymphoproliferative disease in human peripheral blood mononuclear cell-injected scid mice. I. T lymphocyte requirement for b cell tumor generation. J. Exp. Med. 1992, 176, 1763-1767.
78. Johannessen, I.; Asghar, M.; Crawford, D.H. Essential role for t cells in human b-cell lymphoproliferative disease development in severe combined immunodeficient mice. Br. J. Haematol. 2000, 109, 600-610.
79. Baiocchi, R.A.; Ross, M.E.; Tan, J.C.; Chou, C.C.; Sullivan, L.; Haldar, S.; Monne, M.; Seiden, M.V.; Narula, S.K.; Sklar, J., et al. Lymphomagenesis in the scid-hu mouse involves abundant production of human interleukin-10. Blood 1995, 85, 1063-1074.
80. Piovan, E.; Tosello, V.; Indraccolo, S.; Cabrelle, A.; Baesso, I.; Trentin, L.; Zamarchi, R.; Tamamura, H.; Fujii, N.; Semenzato, G., et al. Chemokine receptor expression in EBV-associated lymphoproliferation in hu/scid mice: Implications for cxcl12/cxcr4 axis in lymphoma generation. Blood 2005, 105, 931-939.
81. Dierksheide, J.E.; Baiocchi, R.A.; Ferketich, A.K.; Roychowdhury, S.; Pelletier, R.P.; Eisenbeis, C.F.; Caligiuri, M.A.; VanBuskirk, A.M. Ifn-gamma gene polymorphisms associate with development of EBV+ lymphoproliferative disease in hu pbl-scid mice. Blood 2005, 105, 1558-1565.
82. White, R.E.; Ramer, P.C.; Naresh, K.N.; Meixlsperger, S.; Pinaud, L.; Rooney, C.; Savoldo, B.; Coutinho, R.; Bodor, C.; Gribben, J., et al. Ebna3b-deficient EBV promotes b cell lymphomagenesis in humanized mice and is found in human tumors. J. Clin. Invest. 2012, 122, 1487-1502.
83. Lacerda, J.F.; Ladanyi, M.; Louie, D.C.; Fernandez, J.M.; Papadopoulos, E.B.; O'Reilly, R.J. Human epstein-barr virus (EBV)-specific cytotoxic t lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced b cell lymphoproliferations in xenografted c.B-17 scid/scid mice. J. Exp. Med. 1996, 183, 1215-1228.
84. Randhawa, P.S.; Whiteside, T.L.; Zeevi, A.; Elder, E.M.; Rao, A.S.; Demetris, A.J.; Weng, X.; Valdivia, L.A.; Rakela, J.; Nalesnik, M.A. Effects of immunotherapy on experimental immunodeficiency-related lymphoproliferative disease. Transplantation 1998, 65, 264-268.
85. May, K.F., Jr.; Roychowdhury, S.; Bhatt, D.; Kocak, E.; Bai, X.F.; Liu, J.Q.; Ferketich, A.K.; Martin, E.W., Jr.; Caligiuri, M.A.; Zheng, P., et al. Anti-human ctla-4 monoclonal antibody promotes t-cell expansion and immunity in a hu-pbl-scid model: A new method for preclinical screening of costimulatory monoclonal antibodies. Blood 2005, 105, 1114-1120.
86. Eisenbeis, C.F.; Grainger, A.; Fischer, B.; Baiocchi, R.A.; Carrodeguas, L.; Roychowdhury, S.; Chen, L.; Banks, A.L.; Davis, T.; Young, D., et al. Combination immunotherapy of b-cell non-hodgkin's lymphoma with rituximab and interleukin-2: A preclinical and phase i study. Clin. Cancer Res. 2004, 10, 6101-6110.
87. Baiocchi, R.A.; Ward, J.S.; Carrodeguas, L.; Eisenbeis, C.F.; Peng, R.; Roychowdhury, S.; Vourganti, S.; Sekula, T.; O'Brien, M.; Moeschberger, M., et al. Gm-csf and il-2 induce specific cellular immunity and provide protection against epstein-barr virus lymphoproliferative disorder. J. Clin. Invest. 2001, 108, 887-894.
88. Baiocchi, R.A.; Caligiuri, M.A. Low-dose interleukin 2 prevents the development of epstein-barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.P. With EBV-seropositive human peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA 1994, 91, 5577-5581.
89. Bohlen, H.; Manzke, O.; Titzer, S.; Lorenzen, J.; Kube, D.; Engert, A.; Abken, H.; Wolf, J.; Diehl, V.; Tesch, H. Prevention of epstein-barr virus-induced human b-cell lymphoma in severe combined immunodeficient mice treated with cd3xcd19 bispecific antibodies, cd28 monospecific antibodies, and autologous t cells. Cancer Res. 1997, 57, 1704-1709.
90. Lim, W.H.; Kireta, S.; Russ, G.R.; Coates, P.T. Human plasmacytoid dendritic cells regulate immune responses to epstein-barr virus (EBV) infection and delay EBV-related mortality in humanized nod-scid mice. Blood 2007, 109, 1043-1050.
91. Franken, M.; Estabrooks, A.; Cavacini, L.; Sherburne, B.; Wang, F.; Scadden, D.T. Epstein-barr virus-driven gene therapy for EBV-related lymphomas. Nat. Med. 1996, 2, 1379-1382.
92. Gurer, C.; Strowig, T.; Brilot, F.; Pack, M.; Trumpfheller, C.; Arrey, F.; Park, C.G.; Steinman, R.M.; Munz, C. Targeting the nuclear antigen 1 of epstein-barr virus to the human endocytic receptor dec-205 stimulates protective t-cell responses. Blood 2008, 112, 1231-1239.
93. Shultz, L.D.; Saito, Y.; Najima, Y.; Tanaka, S.; Ochi, T.; Tomizawa, M.; Doi, T.; Sone, A.; Suzuki, N.; Fujiwara, H., et al. Generation of functional human t-cell subsets with hla-restricted immune responses in hla class i expressing nod/scid/il2r gamma(null) humanized mice. Proc. Natl. Acad. Sci. USA 2010, 107, 13022-13027.
94. Henter, J.I.; Horne, A.; Arico, M.; Egeler, R.M.; Filipovich, A.H.; Imashuku, S.; Ladisch, S.; McClain, K.; Webb, D.; Winiarski, J., et al. Hlh-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr. Blood Cancer 2007, 48, 124-131.
95. Kikuta, H.; Sakiyama, Y.; Matsumoto, S.; Oh-Ishi, T.; Nakano, T.; Nagashima, T.; Oka, T.; Hironaka, T.; Hirai, K. Fatal epstein-barr virus-associated hemophagocytic syndrome. Blood 1993, 82, 3259-3264.
96. Kawaguchi, H.; Miyashita, T.; Herbst, H.; Niedobitek, G.; Asada, M.; Tsuchida, M.; Hanada, R.; Kinoshita, A.; Sakurai, M.; Kobayashi, N., et al. Epstein-barr virus-infected t lymphocytes in epstein-barr virus-associated hemophagocytic syndrome. J. Clin. Invest. 1993, 92, 1444-1450.
97. Lay, J.D.; Tsao, C.J.; Chen, J.Y.; Kadin, M.E.; Su, I.J. Upregulation of tumor necrosis factor-alpha gene by epstein-barr virus and activation of macrophages in epstein-barr virus-infected t cells in the pathogenesis of hemophagocytic syndrome. J. Clin. Invest. 1997, 100, 1969-1979.
98. Yang, X.; Wada, T.; Imadome, K.; Nishida, N.; Mukai, T.; Fujiwara, M.; Kawashima, H.; Kato, F.; Fujiwara, S.; Yachie, A., et al. Characterization of epstein-barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with x-linked lymphoproliferative syndrome type 1 and type 2. Herpesviridae 2012, 3, 1.
99. Imadome, K.; Yajima, M.; Arai, A.; Nakazawa, A.; Kawano, F.; Ichikawa, S.; Shimizu, N.; Yamamoto, N.; Morio, T.; Ohga, S., et al. Novel mouse xenograft models reveal a critical role of cd4+ t cells in the proliferation of EBV-infected t and nk cells. PLoS Pathog. 2011, 7, e1002326.
100. McInnes, I.B.; Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 2011, 365, 2205-2219.
101. Niller, H.H.; Wolf, H.; Ay, E.; Minarovits, J. Epigenetic dysregulation of epstein-barr virus latency and development of autoimmune disease. Adv. Exp. Med. Biol 2011, 711, 82-102.
102. Toussirot, E.; Roudier, J. Pathophysiological links between rheumatoid arthritis and the epstein-barr virus: An update. Joint Bone Spine 2007, 74, 418-426.
103. Takei, M.; Mitamura, K.; Fujiwara, S.; Horie, T.; Ryu, J.; Osaka, S.; Yoshino, S.; Sawada, S. Detection of epstein-barr virus-encoded small rna 1 and latent membrane protein 1 in synovial lining cells from rheumatoid arthritis patients. Int. Immunol. 1997, 9, 739-743.
104. Gorantla, S.; Makarov, E.; Finke-Dwyer, J.; Gebhart, C.L.; Domm, W.; Dewhurst, S.; Gendelman, H.E.; Poluektova, L.Y. Cd8+ cell depletion accelerates hiv-1 immunopathology in humanized mice. J. Immunol. 2010, 184, 7082-7091.
105. Watanabe, Y.; Takahashi, T.; Okajima, A.; Shiokawa, M.; Ishii, N.; Katano, I.; Ito, R.; Ito, M.; Minegishi, M.; Minegishi, N., et al. The analysis of the functions of human b and t cells in humanized nod/shi-scid/gammac(null) (nog) mice (hu-hsc nog mice). Int. Immunol. 2009, 21, 843-858.
106. Danner, R.; Chaudhari, S.N.; Rosenberger, J.; Surls, J.; Richie, T.L.; Brumeanu, T.D.; Casares, S. Expression of hla class ii molecules in humanized nod.Rag1ko.Il2rgcko mice is critical for development and function of human t and b cells. PLoS One 2011, 6, e19826.
107. Lee, M.A.; Yates, J.L. Bhrf1 of epstein-barr virus, which is homologous to human proto-oncogene bcl2, is not essential for transformation of b cells or for virus replication in vitro. J. Virol. 1992, 66, 1899-1906.
108. Shimizu, N.; Yoshiyama, H.; Takada, K. Clonal propagation of epstein-barr virus (EBV) recombinants in EBV-negative akata cells. J. Virol. 1996, 70, 7260-7263.
109. Swaminathan, S.; Hesselton, R.; Sullivan, J.; Kieff, E. Epstein-barr virus recombinants with specifically mutated bcrf1 genes. J. Virol. 1993, 67, 7406-7413.
110. Okano, M. Overview and problematic standpoints of severe chronic active epstein-barr virus infection syndrome. Crit. Rev. Oncol. Hematol. 2002, 44, 273-282.
111. Straus, S.E. Acute progressive epstein-barr virus infections. Annu. Rev. Med. 1992, 43, 437-449.
112. Kimura, H. Pathogenesis of chronic active epstein-barr virus infection: Is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev. Med. Virol. 2006, 16, 251-261.
113. Jaffe, E.S. The 2008 who classification of lymphomas: Implications for clinical practice and translational research. Hematology Am. Soc. Hematol. Edu. Program 2009, 523-531.
114. Yuling, H.; Ruijing, X.; Li, L.; Xiang, J.; Rui, Z.; Yujuan, W.; Lijun, Z.; Chunxian, D.; Xinti, T.; Wei, X., et al. Ebv-induced human cd8+ nkt cells suppress tumorigenesis by EBV-associated malignancies. Cancer Res. 2009, 69, 7935-7944.
115. Strowig, T.; Rongvaux, A.; Rathinam, C.; Takizawa, H.; Borsotti, C.; Philbrick, W.; Eynon, E.E.; Manz, M.G.; Flavell, R.A. Transgenic expression of human signal regulatory protein alpha in rag2-/-gamma(c)-/- mice improves engraftment of human hematopoietic cells in humanized mice. Proc. Natl. Acad. Sci. USA 2011, 108, 13218-13223.
116. Legrand, N.; Huntington, N.D.; Nagasawa, M.; Bakker, A.Q.; Schotte, R.; Strick-Marchand, H.; de Geus, S.J.; Pouw, S.M.; Bohne, M.; Voordouw, A., et al. Functional cd47/signal regulatory protein alpha (sirp(alpha)) interaction is required for optimal human t- and natural killer- (NK) cell homeostasis in vivo. Proc. Natl. Acad. Sci. USA 2011, 108, 13224-13229.
117. Willinger, T.; Rongvaux, A.; Strowig, T.; Manz, M.G.; Flavell, R.A. Improving human hemato-lymphoid-system mice by cytokine knock-in gene replacement. Trends Immunol. 2011, 32, 321-327.